Chemoinformaics analysis of GAMMA-L-GLUTAMYL-L-LEUCINE
Molecular Weight | 259.282 | nRot | 8 |
Heavy Atom Molecular Weight | 240.13 | nRig | 3 |
Exact Molecular Weight | 259.13 | nRing | 0 |
Solubility: LogS | -1.356 | nHRing | 0 |
Solubility: LogP | -2.416 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 37.2491 |
nHD | 2 | BPOL | 22.8309 |
QED | 0.478 |
Synth | 2.751 |
Natural Product Likeliness | 0.528 |
NR-PPAR-gamma | 0.043 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.037 |
HIA | 0.064 |
CACO-2 | -6.232 |
MDCK | 0.00497401 |
BBB | 0.567 |
PPB | 0.0803306 |
VDSS | 0.371 |
FU | 0.801316 |
CYP1A2-inh | 0.005 |
CYP1A2-sub | 0.019 |
CYP2c19-inh | 0.053 |
CYP2c19-sub | 0.041 |
CYP2c9-inh | 0.06 |
CYP2c9-sub | 0.768 |
CYP2d6-inh | 0.068 |
CYP2d6-sub | 0.116 |
CYP3a4-inh | 0.022 |
CYP3a4-sub | 0.009 |
CL | 4.359 |
T12 | 0.733 |
hERG | 0.009 |
Ames | 0.013 |
ROA | 0.011 |
SkinSen | 0.189 |
Carcinogencity | 0.025 |
EI | 0.052 |
Respiratory | 0.041 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.647068 |